Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for DECOY20 with or without tislelizumab in adults with advanced solid tumors across Phase 1 and Phase 2. The listed i…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Long Term Prediction of MASH-related HCC Risk by Proteomics
A University Hospital, Bordeaux-sponsored study is examining long-term prediction of hepatocellular carcinoma risk in metabolic-associated s…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
A clinical trial update describes long-term safety outcomes in patients previously treated with RP1, RP2, or RP3 and is currently recruiting…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC [Phase 2]
A Phase 2 clinical trial evaluating Yttrium-90 microsphere injection in combination with targeted immunotherapy for hepatocellular carcinoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer [Phase 1, Phase 2]
A phase 1/2 study evaluating nivolumab and relatlimab in combination with bevacizumab for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence [Phase 2]
Phase 2, single-arm trial of Icaritin Soft Capsules as adjuvant therapy for hepatocellular carcinoma patients at high risk of postoperative …
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Liver and Biliary Tumor Tissue Registry
Mayo Clinic's Liver and Biliary Tumor Tissue Registry (NCT02917759) has been terminated.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma [Phase 3]
Phase III clinical trial evaluating rilvegostomig plus bevacizumab, with or without tremelimumab, as first-line therapy for hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
This completed clinical trial investigated proteomic biomarkers to predict outcomes after locoregional treatments in hepatocellular carcinom…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
This clinical trial update reports on real-world outcomes and safety of atezolizumab in routine practice. It includes patients with urotheli…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
This clinical trial update describes efforts to characterize disease biology, treatment strategies, and toxicity in older adults with hepato…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma [Phase 1]
A Phase 1 clinical trial evaluating IL1RAP-targeting CAR-T cells for relapsed/refractory hepatocellular carcinoma is currently recruiting at…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer
A clinical trial is studying whether emotional disorders influence response to immune checkpoint inhibitor therapy in liver cancer and is cu…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression [Phase 2]
Phase 2 clinical trial evaluating ABSK-011 plus best supportive care versus placebo plus BSC in previously treated advanced hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients
This is a completed clinical trial evaluating whether adding TCC Cocktail to transarterial chemoembolization (TACE) improves survival in unr…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study [Phase 2]
This clinical trial entry describes a Phase 2 single-arm exploratory study of combining Ivarmacitinib, camrelizumab, and apatinib in unresec…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: NWRD06 DNA Plasmid for HCC After Curative Resection. [Phase 2]
A Phase 2 clinical trial evaluating NWRD06 DNA plasmid for hepatocellular carcinoma after curative resection is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: DEB-TACE vs cTACE in HCC After TIPS [Phase 3]
A Phase 3 clinical trial comparing drug-eluting bead TACE (DEB-TACE) with conventional TACE (cTACE) in hepatocellular carcinoma patients aft…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: First-Line Lenvatinib in Child-Pugh B Patients With HCC Unsuitable for Curative Treatment [Phase 2]
A Phase 2 clinical trial is evaluating first-line lenvatinib in patients with Child-Pugh B liver function and advanced hepatocellular carcin…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: STOP HCC-GAAD-APAC-Thailand [NA]
The STOP HCC-GAAD-APAC-Thailand trial sponsored by Mahidol University is currently enrolling by invitation for hepatocellular carcinoma in p…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis [Phase 2]
A Phase 2 clinical trial evaluating the combination of tremelimumab and durvalumab in advanced hepatocellular carcinoma patients with Child-…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes
This clinical trial update examines the efficacy and outcomes of immune checkpoint inhibitors in patients with hepatocellular carcinoma; the…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer
This clinical trial update investigates how prevalent Alpha-1-antitrypsin deficiency is among patients with hepatocellular carcinoma arising…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: β-alanine in the Treatment of Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial is investigating β-alanine in the treatment of advanced hepatocellular carcinoma and is currently recruiting.